Neuro Oncology Market Analysis and Reports | Australia Conference Series

Market Analysis - Neuro Oncology 2020

Market Analysis:

Neuro Oncology 2020 welcomes attendees, presenters and exhibitors from all over the world to Brisbane, Australia. We are delighted to invite you all to attend the 6th International Conference on Neuro-Oncology and Brain Tumor which is going to be held during June 22-23, 2020 Brisbane, Australia.

The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Neuro Oncology 2020, where you will be sure to have a meaningful experience with scholars from around the world. All members of the Neuro Oncology 2020 organizing committee look forward to meeting you in Brisbane, Australia.

Why Australia:

Cancer Australia is the lead tumour control agency to the Australia. The organisation was founded to raise cancer awareness to support those affected by cancer within Australia and its regions. The main ambition of the organisation is to advise the Government on cancer control, develop policies, and to assist those living with cancer.

Cancer Australia collaborates including a wide range of groups, including those affected by cancer, service providers with an interest in cancer control, as well as stakeholders. The agency also focuses on populations who experience poorer health outcomes, with aboriginal Australians living in remote areas within Australia. In August 2014-2018 Cancer Australia, launched the first national Pediatric Cancer

Importance and Scope:

6th International Conference on Neuro-Oncology and Brain Tumor is a unique forum to bring together worldwide distinguished academics in the field of Neurooncology, brain researchers, brain tumor professionals, scientists, academic scientists, industry researchers, scholars to exchange about state of the art research and technologies.

Aim of this conference is stimulate new ideas for treatment that will be beneficial across the spectrum of Neurooncology and Brain tumor.

Conferences, National symposiums and Workshops provide a dedicated forum for the advancement, execution and exchange of information about Neuro Oncology and Brain tumor and its allied areas.

Major Associations and Societies of Neuro-Oncology and Brain Tumor Worldwide:

  • Asian Society for Neuro-Oncology
  • Australian Oncology Social Work Inc
  • SNO Society for Neuro-Oncology
  • Royal Society of London
  • American Society of Clinical Oncology
  • American Academy of Neurology
  • The brain & behavior research foundation
  • ESNR European Society of Neuroradiology
  • American Brain Tumour Association
  • American Cancer Society
  • Canadian Cancer Society
  • National Brain Tumor Society
  • The Neuro Association
  • British neuroscience association
  • British Neuro-oncology Society
  • Canadian Cancer Society

Overview of Neuro-oncology and Brain tumour:

An important area of clinical Neuro-Oncology and Brain Tumour that is increasingly relevant as survivorship increases and as patients experience potential morbidities associated with new therapies. Neuro-Oncology is the study of Brain and Spinal cord neoplasms, many of which are   (at least eventually) very dangerous and life-threatening (Astrocytoma, Glioma, Glioblastoma multiforme, Ependymoma, Pontine Glioma, and Brain stem tumors are among the many examples of these). Among the Malignant Brain cancers, Gliomas of the brainstem and pons, Glioblastoma multiform, and high-grade (highly anaplastic) Astrocytoma are among the worst.

Geographically market is segmented into Europe, North America, Latin America, Asia pacific, and Middle East and Africa. According to market study, Market Value for Neuro Oncology (i.e. on Brain Cancer and CNS Tumors) will be more than double to $ 623 Million by 2020. A major part of research is going on the top Universities on across the globe. Many companies are associated with various diagnostic instruments and other therapeutics. Besides this various societies and research labs are also associated in this research field.

Who Should Attend?

  • Directors
  • Head of Department
  • Professors
  • Industrial Researchers
  • Neuro-oncologist
  • Brain cancer specialists
  • Radiation Oncologists
  • Oncologists
  • Cancer Pharmaceutical Companies
  • Cancer Institutes
  • Neuropediatricians
  • Neurosurgeons
  • Radiation oncologists
  • Neuro-Pathologists
  • Rehabilitation Specialists
  • Research and Development Department.
  • Laboratory Professionals
  • Instrument Industries
  • Ph.D. Students
  • Upcoming researchers
  • Business delegate
  • Nursing scholars
  • Cancer Researchers and Students from academia in the research of Neuro-oncology, Neurooncology Associations, Brain cancer societies, cancer communities

Target Audience:

Academia: 65%

Industry: 25%

Others: 10%

Target Audience for the conference are Physicians and Allied Health Professionals in the field of:

  •         Adult Medical Oncology
  •         Pediatric Oncology and Hematology
  •         Neuro-Oncology
  •         Neurosurgery
  •         Radiation Oncology
  •         Neuropathology in cancer

For more details please visit:

 Benefits of attending:

  • Networking Opportunities, Grow Your Professional Network
  • Build Your Knowledge Base
  • Expand Your Resources
  • Meet Experts & Influencers Face to Face
  • Learning in a New Space
  • Break Out of Your Comfort Zone
  • New Tips & Tactics
  • Greater Focus
  • Top Industries Representation
  • Abstracts will be published in the conference souvenir and respective International journals
  • Each Abstract will receive unique (DOI) Number provided by Cross Ref
  • Website visibility to more than 35K visitors in less than 6 months
  •  Laudable talks by the top-notch of the Global Scientific Community
  • The Serendipity of the Random Workshop
  • Will be felicitated with International Organizing Committee Member (IOCM)
  • Remarkable Awards and Global Recognition to meritorious Researchers